Healthcare
Inflexion takes minority stake in European LifeCare Group
Investment is drawn from the £250m vehicle Inflexion Enterprise Fund IV, which closed in 2016
Riverside generates 4.3x on sale of Euromed
Riverside makes the divestment from its $340m buyout vehicle, Riverside Europe Fund V
V-Bio Ventures et al. invest €37m in Camel-IDS
Consortium of investors backs series-A round for Belgium-based biotech company Camel-IDS
Neuberger Berman, NB Aurora exit General Medical Merate
NB's stake was acquired by the Sordi family and Kangda Medical Equipment Group
Waterland's Schönes Leben acquires Gut Köttenich
New bolt-on Gut Köttenich Group operates 14 nursing homes across 11 locations
Albion invests £5m in The Evewell
Women's health clinic will look to capitalise on increasing demand for fertility treatments
Vaaka Partners invests in Nordic Healthcare Group
GP invests via Vaaka Partners Buyout Fund III, which closed on its €225m hard-cap last year
Roivant raises further $200m from NovaQuest et al.
Latest round follows massive $1.1bn investment led by SoftBank Vision Fund last year
F2i holds €3.6bn final close for third fund
Vehicle was launched with a €3.3bn target and held a €3.14bn first close in December 2017
Quadriga sells Dorea Familie
GP makes the divestment from Quadriga Capital Private Equity Fund IV, a €529.1m buyout fund
AMP Capital in talks to acquire CMG
Transaction would be the Australian manager's second move into the UK care sector
Forbion leads €17m series-C for Omeicos
VC firm was joined by existing investors, including Vesalius, Remiges, SMS, KfW and HTGF
CVC to partially exit Elsan to trade
CVC's hospital operator Elsan to sell division Clinique Toulouse-Lautrec, say press reports
Montreux Equity et al. in $97m round for GC Aesthetics
Financing includes a debt package provided by credit platform Hayfin Capital Management
Principia backs Gada
Company's management will retain the remaining minority holding and continue to lead the business
ArchiMed holds first close for MED Platform I
Healthcare-focused mid-cap buy-and-build fund raises less than two thirds of its €800m target
VC-backed Themis announces IPO price range
Size of the offering for Austria-based Themis is €55.3m – at the high-end of the price range
EQT to take Karo Pharma private for SEK 6bn
Offer of SEK 36.90 per share is unanimously recommended to shareholders by the board
Germany's Protembis raises $10m series-A round
Series-A round is backed by a consortium of investors including Seed Fonds III
Ysios Capital, OrbiMed lead €79m series-C for Galecto
HBM, Bristol Myers-Squibb, Maverick Ventures and Seventure Partners also take part in the round
Mezzanine Management backs Optimapharm with €10m
Transaction marks Mezzanine Management’s first investment in the Croatian market
Caledonia sells Choice Care to Icon for £152.5m
Sale of the care group generated a 1.9x return for the vendor following a five-year holding
Inveready launches new ICT fund, closes biotech vehicle
VC house also closes its Inveready Biotech III fund, after just three months on the road
ICG's DomusVi bolts on Sarrikue Group
DomusVi, a France-based nursing homes operator acquires Basque peer Sarrikue Group
